Related Experiment Video
Updated: Jul 19, 2026
05:14
Comparison of Agreement and Accuracy using Binocular Wavefront Optometer with Autorefractor and Phoropter
Published on: September 16, 2025
Effect of Proview self-tonometry on pharmaceutical compliance
Christopher W Lievens1, Pinakin Gunvant, James Newman
1Southern College of Optometry, Memphis, Tennessee, USA. clievens@sco.edu
Clinical & Experimental Optometry
|October 10, 2006
Summary
The Proview Eye Pressure Monitor did not improve patient compliance with glaucoma eye drop medication in a crossover study. Further research is needed to understand its impact on treatment adherence.
Area of Science:
- Ophthalmology
- Medical Device Technology
- Patient Adherence Research
Background:
- Glaucoma management relies heavily on consistent topical medication adherence.
- Patient compliance with eye drop regimens is a significant challenge in glaucoma treatment.
- Novel monitoring devices aim to improve patient adherence to prescribed treatments.
Purpose of the Study:
- To assess the impact of the Proview Eye Pressure Monitor on patient compliance with topical glaucoma medication.
- To determine if using the Proview Eye Pressure Monitor influences adherence to intraocular pressure-lowering eye drops.
Main Methods:
- A randomized crossover study involving 32 primary open-angle glaucoma patients.
- Patients used the Proview Eye Pressure Monitor for 30 days as an adjunct to their existing glaucoma regimen or received no intervention.
- Medication compliance was measured by weighing returned medication bottles before and after each study phase.
Main Results:
- No statistically significant change in medication consumption was observed with Proview Eye Pressure Monitor use (p = 0.98).
- The device did not demonstrate a positive or negative trend in patient compliance with glaucoma eye drops.
- Analysis indicated that the Proview Eye Pressure Monitor did not significantly alter adherence to adjunct eye drop therapy.
Conclusions:
- The Proview Eye Pressure Monitor did not enhance patient compliance with glaucoma treatment in this study.
- Preliminary findings suggest the device may potentially hinder adherence to glaucoma medication regimens.
- Further investigation is warranted to explore the efficacy of the Proview Eye Pressure Monitor in improving glaucoma treatment adherence.
Related Concept Videos
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...